Pearson Releases 2023 Annual Report and Form 20-F
Pearson Releases 2023 Annual Report and Form 20-F
PR Newswire
LONDON, March 14, 2024
LONDON, March 14, 2024 /PRNewswire/ -- Pearson (FTSE: PSON.L), the world's leading learning company, announces that the following documents have been published today and are available on its investor relations website.
- Annual Report and Accounts for the year ended 31 December 2023 (the "Annual Report")
- Annual Report on Form 20-F for the year ended 31 December 2023 (the "20-F")
The Annual Report has been submitted to the National Storage Mechanism in accordance with Listing Rule 9.6.1 and will shortly be available for inspection in unedited full text on their website.
The 20-F has today been filed with the U.S. Securities and Exchange Commission.
A hard copy of the complete audited financial statements can be obtained free of charge from the Company Secretary at companysecretary@pearson.com.
This announcement is made in accordance with DTR 6.3.5R(1A).
About Pearson
At Pearson, our purpose is simple: to add life to a lifetime of learning. We believe that every learning opportunity is a chance for a personal breakthrough. That's why our c. 18,000 Pearson employees are committed to creating vibrant and enriching learning experiences designed for real-life impact. We are the world's leading learning company, serving customers in nearly 200 countries with digital content, assessments, qualifications, and data. For us, learning isn't just what we do. It's who we are. Visit us at pearsonplc.com.
Media Contact
Dan.Nelson@Pearson.com
SOURCE Pearson
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth